Paclitaxel/ carboplatin/ bevacizumab in non-small cell lung cancer patients induces peripheral effector CD8 T cell proliferation that could be prone for treatment with checkpoint inhibitors

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 30; p. ii7
Main Authors Dumoulin, D., de Goeje, P., Poncin, M., Bezemer, K., Groen, H.J.M., Smit, E.F., Dingemans, A.-M.C., Kunert, A., Hendriks, R., Aerts, J.G.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.04.2019
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdz073.001